Loading...
ALTAO logo

AtonENXTPA:ALTAO Stock Report

Market Cap €8.6m
Share Price
n/a
1Y26.2%
7D0%
1D1.9%
Portfolio Value
View

Aton

ENXTPA:ALTAO Stock Report

Market Cap: €8.6m

ALTAO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW503,479 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
503,479 investors already sharing narratives

Aton Competitors

Price History & Performance

Summary of share price highs, lows and changes for Aton
Historical stock prices
Current Share Price€0.011
52 Week High€0.029
52 Week Low€0.005
Beta0.67
1 Month Change-18.46%
3 Month Change70.97%
1 Year Change26.19%
3 Year Change-80.55%
5 Year Change-94.08%
Change since IPO-90.13%

Recent News & Updates

Analysis Article Dec 19

Is Aton (EPA:ALTAO) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Recent updates

Analysis Article Dec 19

Is Aton (EPA:ALTAO) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

ALTAOFR BiotechsFR Market
7D0%9.3%0.9%
1Y26.2%376.0%4.1%

Return vs Industry: ALTAO underperformed the French Biotechs industry which returned 376% over the past year.

Return vs Market: ALTAO exceeded the French Market which returned 4.1% over the past year.

Price Volatility

Is ALTAO's price volatile compared to industry and market?
ALTAO volatility
ALTAO Average Weekly Movement40.9%
Biotechs Industry Average Movement8.5%
Market Average Movement5.1%
10% most volatile stocks in FR Market11.0%
10% least volatile stocks in FR Market2.5%

Stable Share Price: ALTAO's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: ALTAO's weekly volatility has increased from 22% to 41% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19989Ayikoele Atayiwww.aton-group.com

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis.

Aton Fundamentals Summary

How do Aton's earnings and revenue compare to its market cap?
ALTAO fundamental statistics
Market cap€8.61m
Earnings (TTM)-€115.68k
Revenue (TTM)€656.93k
13.4x
P/S Ratio
-75.9x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALTAO income statement (TTM)
Revenue€656.93k
Cost of Revenue€247.90k
Gross Profit€409.03k
Other Expenses€524.71k
Earnings-€115.68k

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.00014
Gross Margin62.26%
Net Profit Margin-17.61%
Debt/Equity Ratio302.8%

How did ALTAO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 18:08
End of Day Share Price 2026/07/08 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aton is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.